Prosecution Insights
Last updated: October 04, 2026

VENCLOSE, INC.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

VENCLOSE, INC. has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This portfolio is overseen by a single distinct examiner and a sole distinct art unit. ZIEGLER, ABIGAIL M is the busiest examiner, managing 1 pending office action.

The active prosecution indicates a small footprint in the Medical Devices & Mechanical Engineering space. Because the portfolio features only a single distinct examiner, ZIEGLER, ABIGAIL M, the results are currently dependent on a single examiner's review. The involvement of a sole distinct art unit confirms that the pending matters are being processed through a single administrative channel. For a practitioner, this means that the prosecution strategy is highly centralized and lacks the complexity of multi-examiner portfolios. The success of the current intellectual property strategy for VENCLOSE, INC. is tied to the resolution of this single pending office action within the specified art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZIEGLER, ABIGAIL M 1 46.3% +49.1%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17239210 METHODS AND SYSTEMS FOR VENOUS DISEASE TREATMENT ZIEGLER, ABIGAIL M 34d

Top Art Units

Art UnitApps
3794 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17239210 METHODS AND SYSTEMS FOR VENOUS DISEASE TREATMENT ZIEGLER, ABIGAIL M 3794 §103 Final Rejection 34d Pending Apr 23, 2021

Managing VENCLOSE, INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month